ARGX argenx SE ADRs

argenx SE, along with its subsidiaries is engaged in the bio-technical research on drugs and pharma processes for the treatment of oncological, autoimmune and inflammatory diseases. This is an ADR of a company whose stock trades outside of the U.S. as the symbol NA:ARGX.

$258.66  -1.60 (-0.62%)
As of 01/26/2022 15:59:56 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Large cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  The Netherlands
Country of incorporation:  The Netherlands
IPO date:  05/18/2017
Outstanding shares:  51,668,315
Average volume:  207,759
Market cap:   $13,692,103,475
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Sedol:      BDVLM39
Valuation   (See tab for details)
PE ratio:   -71.76
PB ratio:   4.53
PS ratio:   27.23
Return on equity:   -6.79%
Net income %:   -39.85%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy